Groundbreaking HIV study launches

Dr Makhema
Dr Makhema

The Botswana Harvard AIDS Institute Partnership (BHP) yesterday launched its inaugural clinical study to look into the effectiveness of antibodies in reducing the acquisition of HIV among high-risk female populations.The research explores a new idea for HIV prevention, investigators explained on Tuesday.

The study, which started in July, targets a maximum of 300 women aged between 18-40 among whom the HIV incidence is leading in sub-Saharan Africa, in addition to glaring disproportions among their male counterparts.

For instance, HIV incidence among 15 to 19-year-olds is reported to be three percent for males, and much more for females at seven percent.

Editor's Comment
Routine child vaccination imperative

The recent Vaccination Day in Motokwe, orchestrated through collaborative efforts between UNICEF, USAID, BRCS, and the Ministry of Health, underscores a commendable stride towards fortifying child health services.The painful reality as reflected by the Ministry of Health's data regarding the decline in routine immunisation coverage since the onset of the pandemic, is a cause for concern.It underscores the urgent need to address the...

Have a Story? Send Us a tip
arrow up